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Abstract: 
The aims of the study were to: (a) examine the number, absolute volume, and type of daily 
medications older women were taking 6 to 12 months post-myocardial infarction (MI); (b) 
describe the financial burden of cardiac medications; and (c) examine the relationship of age, 
education, and income to the number of medications. An analysis of a cross-sectional descriptive 
study of women >65 years of age who were post-MI was used. Most (89%; N = 83) were taking 
at least one cardiac medication, costs per day varied ($0.13–$6.75), and total number of pills 
taken per day was 1 to 19. Age, education, and income did not explain the number of 
medications. Consideration of the financial burden of medications is important to increase 
compliance and foster secondary prevention in older women. 
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Article: 
INTRODUCTION 
Over the past decade, research has illuminated the unique issues related to women and 
cardiovascular disease. Cardiovascular disease is the single leading cause of death and disability 
in women over 50, and 75% of women, ages 60 to 79, have coronary heart disease, a type of 
cardiovascular disease (American Heart Association [AHA], 2006). The average age for a 
woman having her first myocardial infarction (MI) is 70.4 years compared to 65.8 years for men, 
(AHA, 2007). Women experience higher rates of mortality after MI and poorer outcomes, such 
as angina and heart failure, after invasive interventions such as angioplasty and coronary artery 
bypass grafting (Vaccarino et al., 2003, 2005). Poor clinical outcomes in women post-MI in 
conjunction with increased age with MI may require multiple medications to manage the 
symptoms. Subsequently, women with cardiovascular disease have an increased prevalence of 
polypharmacy (Senik & Kadir, 2006). The prefix poly- means more than one (Neufeldt & 
Guralnik, 1988). Thus, the definition of polypharmacy is two or more drugs taken for a period of 
240 days or more (Veehof, Stewart, Haaijer-Ruskamp, & Meyboom-de Jong, 2000). 
“Polypharmacy in the elderly complicates therapy, increases cost, and is a challenge for 
healthcare agencies” (Rollason & Vogt, 2003, p. 817). Although individuals over 65 years of age 
comprise 12% of the population, they account for 33% of prescriptions that are filled by 
pharmacists (Patel, 2003). Pharmacological therapy in the elderly is difficult due to physiological 
changes associated with aging, such as poor absorption and decreased metabolism, and these 
changes may contribute to adverse drug reactions (Trotter, 2001). Because of the effects of one 
medication potentiating or inhibiting the action of another medication (Fulton & Allen, 2005), 
polypharmacy in the older adult contributes to a further decline in renal and hepatic function 
(Denneboom, Dautzenberg, Grol, & DeSmet, 2006), increased fall rates (Reddy, 2006), and 
decreased cognition (Starr et al., 2004) and complicates health care. 
In addition to cardiovascular disease, the elderly often have other comorbid conditions, like 
arthritis and diabetes (Robinson, 2007; Rollason & Vogt, 2003), which may also require 
medications for disease management or prevent the use of some cardiac medications. Elderly 
women are prescribed more cardiac medications, specifically beta-blockers. In fact, women 
significantly used antihypertensive combinations, beta-blockers, diuretics, and angiotensen 
converting enzyme (ACE) inhibitors more than men (Correa-De-Araujo, Miller, Banthin,, & 
Trinh, 2004). Because women have an MI later in life and consume more cardiac medications 
than men, it is important to examine if age is related to the number of medications taken by 
women post-MI. 
In 2003, adults ages 65 and older had the lowest quantitative literacy level of all adult age groups 
(National Center for Education Statistics, 2007). Lack of understanding due to low literacy levels 
may also result in medication noncompliance. A reported variance of 11 to 29% of 
noncompliance is noted in the literature (Claxton, Cramer, & Pierce, 2001; Dunbar-Jacob, 
Bohachick, Mortimer, Sereika, & Foley, 2003), and noncompliance can significantly influence 
health outcomes after MI. If the physiological symptoms persist and there is no communication 
of noncompliance with medications, health-care providers may prescribe additional medications, 
contributing to polypharmacy. Further, nonadherence may also be related to the number of 
medications taken daily. Rudd, Ramesh, Bryant-Kosling, and Guerrero (1993) suggested that 
adherence rates could improve by using fewer medications and longer-acting medications. 
Exploring the relationships of education level to polypharmacy and the number of medications 
post-MI is important, especially for those with low literacy levels. 
Due to the relationship between an individual's literacy level and revenue, income is also an 
important variable to examine in elderly women post-MI. Forty-three percent of individuals with 
low literacy levels live in poverty (Minnesota Literacy Council, n.d). Older women also have 
fewer sources of retirement income than men, and these women's income is only approximately 
$2300 above poverty level (Wu, 2007). The median income of women is slightly more than one-
half that of men, and more importantly, these women's income is only $3,000 above poverty 
level (Beedon & Wu, 2005). An individual is considered to be living in poverty if their yearly 
income is below $10, 210 (Health and Human Services, 2007). In February 2007, Social Security 
payments for elderly individuals averaged $465.60 monthly or $5587.20 annually (Social 
Security Administration, 2007). Therefore, many women with only Social Security income are 
considered within the poverty level. 
Guidelines from the American College of Cardiology and the AHA Task Force on Practice 
Guidelines (Antman et al., 2004) recommend individuals presenting with an MI are treated, 
unless contraindicated, with nitrates, beta-blockers, aspirin, calcium channel blockers, and ACE 
inhibitors. However, the costs of these medications may be unaffordable or place a significant 
burden on elderly women with a fixed income. Although many older adults have enrolled in 
Medicare Part D since the implementation in 2006, a cost savings in the standard Medicare Part 
D occurs only when a person has an annual medication cost of $800 (Moczygemba, 2006). The 
average cost of a Medicare Part D prescription coverage plan is $28.20 per month. Further, 
participants are expected to pay a yearly deductible of $265 for prescriptions (Centers for 
Medicare and Medicaid Services, 2007). These costs, coupled with the increase in costs of food, 
heat, and gas for daily living, poses a substantial financial burden on elderly women. Therefore, 
understanding the associations of income to the number of medications women are taking post-
MI would be important in evaluating the influence of income on polypharmacy. 
AIMS 
The primary aims of this study were to examine the number, absolute volume (total number of 
pills), and type of medications older women were taking daily 6 to 12 months post-MI and to 
describe the actual or potential financial burden of cardiac medications. A secondary aim was to 
examine the relationship of age, education, and income to the number and absolute volume of 
medications taken. 
METHOD 
This descriptive correlation study was an analysis of data collected to examine correlates to 
fatigue in older women 6 to 12 months after MI (Crane, 2005). Eighty-six women from two area 
hospital systems and one cardiovascular clinic in the central southeast region of the United States 
participated in this study. 
PROCEDURE 
Data collection occurred in the home or at a location chosen by the participants. All women 
completed an informed consent and answered questions related to demographics, such as age and 
income. Those individuals with a medical diagnosis of dementia or who could not answer the 
questions were excluded from the study. The principal investigator (PI) or research assistant 
(RA) visually examined all the daily medications the women were taking and verified that the 
women were taking the medications as prescribed on each prescription bottle. Medications that 
were taken periodically for symptom management, for example, a headache, were not included. 
This information was recorded on a form designed by the PI. All data were then entered into 
SPSS 11.5. 
All of the medication information was categorized by classification of the medications, name of 
medications, number of daily doses, and number of pills taken daily. To specifically examine 
cardiac medications, categories were identified based on the AHA's guidelines for treating MIs: 
ACE inhibitors, beta-blockers, and medications to control blood pressure, specifically diuretics 
(Antman et al., 2004). Another category was developed for other cardiac medications not 
specifically recommended by the AHA such as antiarhythmics, calcium channel blockers, and 
nitrates. There were 11 medications in this category. Only 10% or less of the women took these 
medications except for digoxin, which was taken by 13%. This categorization allowed for the 
examination of all cardiac medications while focusing on those medications used most 
frequently. The total number of cardiac medications taken, based on the four categories, and the 
total of all medications taken for each participant in a 24-hour period were calculated. Costs of 
cardiac medications taken in a 24-hour period were also calculated for each participant. 
Estimated costs were based on the lowest prices received from Wal-Mart and Costco pharmacies. 
These pharmacies offer low-cost generics to all Medicare and private prescription-coverage 
individuals (L. D. Moss personal communication with Wal-Mart and Costco pharmacies, 
February 20, 2007). 
Age, education, and income information were derived from the original questionnaire completed 
by the PI or RA. Age was the actual age reported by each participant based on their last birthday 
at the time of data collection. Education was classified into nine categories: (a) 8 years or less, 
(b) 9 to 11 years, (c) high school graduate or General Educational Development (GED), (d) some 
technical school, (e) technical school, (f) some college, (g) baccalaureate degree, (h) some 
graduate education, or (i) graduate degree or higher. Income was divided into categories based 
on increments of $10,000. The lowest income was less than or equal to $10,000, and the top 
income was over $100,000. There was a category for those who did not know their income or 
those who refused to disclose the information. Of the 86 participants, one had an income of 
greater than $100,000, and two did not know their income. Because the one participant with an 
income greater than $100,000 was an outlier and could skew the results, this participant and the 
two who did not know their income were excluded from analysis. Therefore, the final sample for 
this study was 83, and this number of participants had an 80% power to detect a R2 of 0.15 at a 
0.05 significance level with three normally distributed independent variables. 
All data were examined to verify that the assumptions for multiple regressions were met. 
Because the data were normally distributed, no transformations were applied. 
RESULTS 
The age of the individuals in this study ranged from 65 to 91 years of age. Over half of those 
were 75 years or younger. They took an average of seven medications per day and eight pills in a 
24-hour period (see Table 1 and 2). The majority (66%) of the women reported annual household 
incomes above $10,000, indicating they were not in the poverty level. When comparing those 
women with annual incomes $10,000 or below to women whose income was above $10,000, 
women $10,000 or below had fewer years of education, took a greater number of pills in 24 
hours, and took fewer cardiac drugs. 
TABLE 1 Age and Educational Levels by Income (N = 83) 
Variables    ≤ $10,000   > $10,000 
Age    Mean 74.78 (SD 5.301) Mean 75.35 (SD 6.385) 
Educational Level 
 8 years or less   44.4%    7% 
 9–11 years 29.6% 21.1% 
 High school graduate or GED 14.8%    28.1% 
 Some technical school  3.7%    8.8% 
 Some college    7.4%    17.5% 
 Baccalaureate degree   0%    5.3% 
 Graduate degree or higher   0%    7% 
 
Table 2 is omitted from this formatted document. 
 
Income was categorized into two groups: those who reported annual household incomes less or 
equal to $10,000 or more than $10,000. A Mann-Whitney U-test was used to test differences in 
education and the two income levels (less than or equal to $10,000 and more than $10,000). A 
significant difference was noted (p < 0.001) between the two groups. The majority (74%) of 
those with incomes ≤$10,000 had 11 years or less of education compared to 29% for those with 
higher incomes. There were no significant differences in age, total number of pills taken, or total 
number of cardiac drugs taken for each group. 
When examining cardiac drugs, approximately 89% of all the women were taking cardiac drugs 
in three categories: ACE inhibitors, beta-blockers, and diuretics. The most common ACE 
inhibitor was Altace (Ramipril), accounting for 59% of the women, followed by Vasotec 
(Enalapril) for 10%. All other drugs were less than 7%. The most common beta-blocker was 
Lopressor (Metoprolol), with 35% of the women taking this drug. Lasix (Furosemide) was the 
most frequent diuretic, with 68% of the women taking this drug. Over half (52%) of the women 
were taking additional cardiac medications. Most took digoxin, accounting for 13%. The other 
medications in this category had from 1 to 6 women taking each drug; thus, all other medications 
were taken by 7% or less of the women. Table 3 describes the percent of women taking cardiac 
medications by income category. 
 
TABLE 3 Cardiac Medications by Income (N = 83) 
Cardiac medications  ≤$10,000 (n = 27) >$10,000 (n = 56) 
ACE Inhibitors  27 (55.6%)  56 (46.4%) 
Beta-Blockers   27 (66.7%)  56 (71.4%) 
Diuretics   27 (44.4%)  56 (48.2%) 
Other Medications  26 (48.1%)  56 (46.4%) 
 
The financial costs of the cardiac medications ranged from $0.13 to $6.75 per day. Of those with 
annual incomes ≤ $10,000, at least 52% spent up to $2.66 per day or $79.80 per 30-day month. 
Those with incomes greater than $10,000 spent up to $2.07 per day. As expected, the costs of 
cardiac medications were strongly correlated with the number of cardiac pills taken daily (r = 
0.66; p < 0.001). Table 4 details the costs of cardiac medications for each income group based on 
the most and least expensive drugs for ACE inhibitors, beta-blockers, and diuretics. 
TABLE 4 Highest and Lowest Priced Medications by Income (N = 83) 
   Trade (Generic)             ≤ $10,000 (n = 27) > $10,000 (n = 56) 
ACE Inhibitors Altace (Ramipril) ($1.60–$2.01/dose) 37%   25% 
Vasotec (Enalapril) ($0.13/dose)  3.7%   5.4% 
Beta-Blockers Coreg (Carvediolol) ($2.02/dose)  18.5%   3.6% 
Tenormin (Atenolol) ($0.13/dose)  18.5%   14.3% 
Diuretics Maxzide (Triamterene & HCTZ) ($1.44/dose) 0%   1.8% 
Lasix (Furosemide) ($0.13/dose)  44.4%   32.1% 
 
A standard multiple regression was conducted to examine the relationship of the three 
independent variables—age, education, and income (all categories)—to the number of all 
medications, which included cardiac medications and other medications. Although income and 
age were moderately correlated (r = 0.49; p < 0.001), the model was not significant (F = 0.295 
(3, 79); p = 0.829). A second regression analysis was conducted with the total number of only 
cardiac medications as the dependent variable. This model was also nonsignificant (F = 1.171 (3, 
79); p = 0.326). 
DISCUSSION 
Women reported taking an average of seven medications a day. Based on the definitions that 
polypharmacy is two or more drugs taken for a period of 240 days or more (Veehof et al., 2000) 
or five or more drugs taken at the same time (Werden & Preskorn, 2003), polypharmacy was 
prevalent in this sample. Surprisingly, this study did not find that aging was related to 
polypharmacy. Women over the age of 75 years took on average fewer daily medications than 
those 65 to 75 years of age. These results may be related to women not having their prescriptions 
filled. A large study of community-dwelling elders (N = 6,535) noted that adults ages 65 to 80 
were most likely to delay their medications due to costs (Klein, Turvey, & Wallace, 2004) when 
they only had Medicare as insurance or had large personal costs with low personal incomes. It is 
imperative that health-care providers be aware of the potential for polypharmacy in elderly 
women and issues associated with polypharmacy such as delay in filling medication 
prescriptions or taking less medication than prescribed related to financial burden, especially 
those post-MI. Future studies should not only examine the medication but also inquire if older 
adults have had their prescriptions filled. 
Polypharmacy can be concerning for elderly women with lower educational levels. 
Approximately half of the women in this study who had an income in the poverty level had 8 
years or less of education. Another study (Day & Newburger, 2002) that noted that women with 
higher levels of education, on average, have higher earnings than those with lower educational 
levels. Although there was not a significant difference in the educational level and the absolute 
number of medications taken, lower educational levels are concerning in the presence of 
polypharmacy. 
Low education levels are associated with medication nonadherence. In a systematic review, 
Claxton, Cramer, and Pierce (Claxton et al., 2001) documented a 29% noncompliance rate for 
medications among elderly women especially when taking more than two medications. 
Conversely, Dunbar-Jacob et al. (2003) noted medication nonadherence rates between 11–12% 
in those with cardiovascular disease. These varying results may be related to the educational 
level of the participants. Over 80% of the sample in the Dunbar-Jacob et al. study had a high 
school or more education. Elderly women with low educational levels may rely on health-care 
professionals to be their advocate and to provide the necessary education they need to 
knowledgeably discuss medication issues. Therefore, health-care providers must: (a) articulate 
the need to reduce polypharmacy in older women, (b) ensure there is no redundancy by exploring 
the options of using combination drugs or extended release drugs, and (c) work with other 
health-care providers to reduce the number of medications taken daily. 
Physician prescribing habits could potentially impose a financial burden associated with 
polypharmacy in elderly women post-MI. In 2003, the out-of-pocket payments for personal 
health care paid by women was $2,445 and $1,272 for Medicare payments (Robinson, 2007). 
While in this study the difference in the number of medications between the two income groups 
was not statistically significant, the results are clinically significant: There was no difference in 
medication-prescribing practices in those with low or high incomes. Prescribing choices were not 
influenced by income. The majority of the women took at least two cardiac medications daily, 
and the price of the medications did not impact which medications they were taking. This is 
worrisome for women whose income is at or below the poverty level. Although Medicare Part D 
covers a percentage of the expenses, there is a point when the women are financially responsible 
for the medication costs, known as the “donut hole.” Once the women have reached the yearly 
deductible of $265 and the initial coverage limit of $2400, they must pay the full cost of the 
medication until their out of pocket expense reaches $3850. At that point the catastrophic 
insurance is available, where the prices are reduced to the minimum co-pay of $2.15 to $5.35 per 
prescription. This is based on yearly expenses, and they must start over with the deductible the 
first of every January (Centers for Medicare and Medicaid Services, 2007). Those with lower 
incomes may have to make choices or sacrifices related to food, heat, and gas for daily living to 
ensure they can purchase their medications. Because women are more likely to have another MI 
in 6 years after their first MI compared to men (35% to 18% respectively) (AHA, 2006), 
medications are important in older women post-MI. Taking into consideration the income of 
women and the financial burden of medications is an important measure to foster compliance to 
medications and thus, enhance secondary prevention in this vulnerable population. 
LIMITATIONS 
When measuring income, we did not reflect the cost a spouse may spend for medications. This 
would be important to consider in future research to determine household financial burden 
related to family polypharmacy. Comprehension levels were also not addressed when examining 
educational levels. Completing a certain level of formal education does not necessarily reflect the 
ability of an individual to comprehend information either through verbal or written 
communication. The level of comprehension could not only affect the women's ability to 
question their health-care provider's prescribing habits, but may also affect compliance with 
medication regimes. While women who had a diagnosis of dementia or who were unable to 
answer the questions requiring recall were excluded, a lack of a cognitive screen is a limitation 
of this study. Finally, the costs associated with the cardiac medications were based on two 
pharmacies, one in which the individual must be able to afford a membership to use the 
pharmacy services. In future studies it would be important to determine which pharmacies the 
women were using and calculate daily costs based on the prices from the actual pharmacies. The 
women, especially those at the poverty level, may be using a local pharmacy because of issues 
with transportation. The costs associated with local pharmacies could be higher, thus affecting 
the true financial burden of polypharmacy on elderly women post-MI. 
CONCLUSION 
Although the results of this study were not statistically significant when examining age, 
educational levels, and income in relation to the number of medications, it is important to 
heighten awareness of health-care providers to the potential problems associated with 
polypharmacy in elderly women post-MI. Increasing the awareness of the benefits of Medicare 
Part D may assist in counseling elderly women in the application process of Medicare and how 
to evaluate the various available plans. Health-care providers should assess comprehension levels 
and potential financial burdens of these women to ensure compliance with medications. 
Furthermore, evaluating the costs and use of sustained-released medications or combination 
medications to improve adherence and reduce the potential financial burden associated with 
polypharmacy in elderly women post-MI is warranted. 
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